Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis

Fumagalli, C., Ioannou, A., Cappelli, F., Maurer, M. S., Razvi, Y., Porcari, A., Zampieri, M., Perfetto, F., Rauf, M. U., Martinez-Naharro, A., Venneri, L., Petrie, A., Whelan, C., Wechalekar, A., Lachmann, H., Hawkins, P. N., Olivotto, I., Marfella, R., Ungar, A., … Fontana, M. (2025). Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis. JACC: CardioOncology, 7(3), 268–278. https://doi.org/10.1016/j.jaccao.2025.01.018
Authors:
Carlo Fumagalli
Adam Ioannou
Francesco Cappelli
Mathew S Maurer
Yousuf Razvi
Aldostefano Porcari
Mattia Zampieri
Federico Perfetto
Muhammad U Rauf
Ana Martinez-Naharro
Lucia Venneri
Aviva Petrie
Carol Whelan
Ashutosh Wechalekar
Helen Lachmann
Philip N Hawkins
Iacopo Olivotto
Raffaele Marfella
Andrea Ungar
Niccolò Marchionni
Julian D Gillmore
Marianna Fontana
Affiliated Authors:
Mathew S Maurer
Author Keywords:
amyloidosis
attr-ca
cardiomyopathy
care delivery model frailty
outcomes
therapy
Publication Type:
Article
Unique ID:
10.1016/j.jaccao.2025.01.018
PMID:
Publication Date:
Data Source:
PubMed

Record Created: